Search
for
Sort by
Research 26
- Trichological disorders in Organ Transplant Recipients - case report and literature review.
- Integrating multi-omics analyses of Nonomuraea dietziae to reveal the role of soybean oil in [(4′-OH)MeLeu]4-CsA overproduction
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- Role of skin enzymes in metabolism of topical drugs
- The influence of cyclosporine A therapy on sex hormone levels in pre- and post-menopausal women with primary biliary cirrhosis
- Dermatologic Care of the Transplant Patient
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- 13. Wound Healing & Hair
- 5. HIV, Fungal and Infectious Diseases
- 4. Bullous/Mucous Membrane
- 12. Cancer
- Interventions for nail psoriasis
- Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes
- Ascorbigen Induces Dermal Papilla Cell Proliferation in Vitro , but Fails to Modulate Chemotherapy-Induced Alopecia in Vivo
- Hair Changes due to Drugs
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Dermal Delivery of Topically Applied Oligonucleotides via Follicular Transport in Mouse Skin
- Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- CAQ Corner: Basic concepts of transplant immunology
- The use of cyclosporine in dermatology: Part I
- Homing of stem cells to sites of inflammatory brain injury after intracerebral and intravenous administration: a longitudinal imaging study
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2